Why Did Germany Reject Sildenafil OTC Switch?
Executive Summary
Sildenafil was rejected at Germany’s independent switch committee’s most recent meeting. HBW Insight examines some of the arguments for and against the switch put forward by the regulator, members of the committee and the applicant, as recorded in the recently published minutes.
You may also be interested in...
Why Did Germany’s Switch Experts Reject OTC Tadalafil And Sildenafil (Again)?
Germany's Expert Committee for Prescription has once again rejected the OTC switch of sildenafil, as well as tadalafil. The recently published full meeting minutes show key concerns were falsification, misuse and OTC pricing.
Sildenafil, Tadalafil Among Big Hitters On Upcoming German Switch Committee Agenda
Possible OTC switches of erectile dysfunction drugs sildenafil and tadalafil, as well as azelastine and fluticasone propionate combination nasal sprays and migraine drug rizatriptan, are on a packed agenda for the next meeting of the German Expert Committee on Prescription.
German Government Wants Sildenafil, Tadalafil OTC
Germany's Ministry of Health surprised all those present at a recent BAH meeting by announcing it would like to see erectile dysfunction drugs like sildenafil and tadalafil available OTC. Such a move, however, would put the government at odds with drug regulator BfArM's Expert Committee for Prescription, which recently rejected an application for the Rx-to-OTC switch of sildenafil.